Cancer

Teleflex to Acquire Palette Life Sciences

Acquisition will add Barrigel®, a biodegradable sculptable rectal spacer, to Teleflex’s Interventional Urology portfolioWAYNE, Pa., July 26, 2023 (GLOBE NEWSWIRE)…

11 months ago

Napo Pharmaceuticals, a Jaguar Health Company, Supports Gay Men’s Health with Participation in Pineapple Healthcare’s “Butt Stuff Brunch with Dr. Carlton”

Napo Medical Affairs Team Member, who is an HIV/Mytesi® (Crofelemer) Patient, to Participate in Educational PanelSAN FRANCISCO, CA / ACCESSWIRE…

11 months ago

SamanTree Medical Appoints New Chief Executive Officer

Histolog® Scanner has been used in 2000 procedures, adoption is acceleratingLAUSANNE, Switzerland--(BUSINESS WIRE)--#medicalimaging--SamanTree Medical, a medical technology company specializing in…

11 months ago

MindBio Therapeutics Begins Recruitment of Participants for World First LSD-Microdosing Clinical Trial in Cancer Patients Experiencing Emotional Distress

World first take-home approvals for LSD-Microdosing in clinical trials in cancer patientsLSD-Microdosing combined with clinically proven Meaning Centred PsychotherapyVANCOUVER, BC…

11 months ago

AngioDynamics Announces Addition of Lorinda Burgess to Board of Directors

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in…

11 months ago

Champions Oncology Reports Quarterly Revenue of $13.1 Million

Record Annual Revenue of $53.9 MillionHACKENSACK, NJ / ACCESSWIRE / July 24, 2023 / Champions Oncology, Inc. (Nasdaq:CSBR), a leading…

11 months ago

Study Indicates Superiority of VeraForm Marker Over Clips During Breast Cancer Surgery

SAN FRANCISCO, CA / ACCESSWIRE / July 24, 2023 / A recent peer-reviewed study published in the American Journal of…

11 months ago

The U.S. Food and Drug Administration Gives the Green Light to Molecure’s Flagship Program – Phase II Clinical Testing of OATD-01 is Ready for Launch

Press release The U.S. Food and Drug Administration Gives the Green Light to Molecure’s Flagship Program – Phase II Clinical…

11 months ago

Marius Pharmaceuticals Announces Launch of ReThink Testosterone, Disease-State Awareness Initiative for Patients

RALEIGH, N.C., July 24, 2023 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a patient-centric healthcare company specializing in therapies for hypogonadism or…

11 months ago

BMF-219 Induces Complete Responses in Target Acute Myeloid Leukemia (AML) Patient Population

Initial topline data from COVALENT-101 trial revealed 2 complete responses (CRs) out of 5 relapsed/refractory AML patients carrying menin-dependent mutations…

11 months ago